Literature DB >> 10675274

Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells.

R C van der Veen1, T A Dietlin, J Dixon Gray, W Gilmore.   

Abstract

To examine how macrophage-derived nitric oxide (NO) affects T helper (Th) cell activity, T cell clones representing Th1 and Th2 subsets were activated before exposure to stimulated peritoneal macrophages or microglia. Both Th subsets were similarly sensitive to inhibition by NO, indicating that macrophage-derived NO regulates the proliferation of activated Th1 and Th2 cells equally well. Since IFN-gamma production remained intact in NO-treated Th1 cells, we studied whether NO was produced during antigen-specific activation of Th1 cells by unstimulated macrophages. Indeed, T cell proliferation only occurred when a NO synthase inhibitor was included, while IFN-gamma was essential for the induction of NO. These studies demonstrate that macrophages produce NO following antigen presentation to Th1 cells and that macrophage-derived NO inhibits Th1 and Th2 cell proliferation without inhibiting cytokine production. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675274     DOI: 10.1006/cimm.1999.1597

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  16 in total

1.  Corneal stromal cells selectively inhibit production of anti-inflammatory cytokines by activated T cells.

Authors:  V Holán; A Vítová; J Pindjáková; M Krulová; A Zajícová; M Filipec
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 2.  End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology.

Authors:  Mirjana Dimitrijevic; Stanislava Stanojevic; Natasa Kustrimovic; Gordana Leposavic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Central role for interleukin-4 in regulating nitric oxide-mediated inhibition of T-cell proliferation and gamma interferon production in schistosomiasis.

Authors:  Elisabeth A Patton; Anne C La Flamme; Joao A Pedras-Vasoncelos; Edward J Pearce
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  IL-5 induces proliferation and activation of microglia via an unknown receptor.

Authors:  S M Liva; J de Vellis
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

5.  TNFR1 signalling is a critical checkpoint for developing macrophages that control of T-cell proliferation.

Authors:  Ben J E Raveney; David A Copland; Claudia J Calder; Andrew D Dick; Lindsay B Nicholson
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

6.  Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis.

Authors:  D A Copland; K Hussain; S Baalasubramanian; T R Hughes; B P Morgan; H Xu; A D Dick; L B Nicholson
Journal:  Clin Exp Immunol       Date:  2009-12-04       Impact factor: 4.330

7.  Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.

Authors:  Mark J Bluth; Lisa C Zaba; Dariush Moussai; Mayte Suárez-Fariñas; Helen Kaporis; Linda Fan; Katherine C Pierson; Traci R White; Alexander Pitts-Kiefer; Judilyn Fuentes-Duculan; Emma Guttman-Yassky; James G Krueger; Michelle A Lowes; John A Carucci
Journal:  J Invest Dermatol       Date:  2009-04-23       Impact factor: 8.551

8.  Dehydroepiandrosterone and metformin regulate proliferation of murine T lymphocytes.

Authors:  M E Solano; V Sander; M R Wald; A B Motta
Journal:  Clin Exp Immunol       Date:  2008-06-28       Impact factor: 4.330

Review 9.  Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis.

Authors:  Tanuja Chitnis; Samia J Khoury
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Monocyte-derived IL-5 reduces TNF production by Mycobacterium tuberculosis-specific CD4 T cells during SIV/M. tuberculosis coinfection.

Authors:  Collin R Diedrich; Joshua T Mattila; JoAnne L Flynn
Journal:  J Immunol       Date:  2013-05-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.